CVS has introduced an replace on buying and selling and outlook for the present monetary yr.
In interim outcomes launched on 25 March 2021, the corporate reported sturdy efficiency for the primary eight months of the present monetary yr – and that momentum has continued, with gross sales remaining sturdy and a gradual enhance in buyer demand from the top of the final quarter.
The assertion continued: “The RCVS issued revised steering in the direction of the top of March 2021, transitioning from important companies solely to permitting the complete vary of procedures topic to skilled judgement and acceptable biosecurity.
“This, coupled with the continued supply of the vaccination programme and additional easing of lockdown restrictions, means the board is more and more assured that this sturdy efficiency will proceed for the remaining months of this monetary yr.
“Consequently, the group now expects full-year income to be forward of present administration expectations and adjusted [earnings before interest, taxes, depreciation and amortisation] to be comfortably forward.”
CVS has additionally introduced the acquisition of Greensands Veterinary Clinic, a small animal apply in Hertfordshire, which accomplished on 29 April 2021.
The corporate plans to supply additional particulars on its monetary outcomes for the yr ending 30 June 2021 in a pre-closed interval assertion, anticipated to be issued on 20 July 2021.